Indeed, the synthetic lethal effect of poly-(ADP-Ribose) polymerase (PARP) inhibitors (PARPi) has been suggested in an in vitro renal cell carcinoma model harboring PBRM1 mutations11. This evidence concerns the gene PBRM1 and hereditary clear cell renal cell carcinoma.